[Asia Economy Reporter Junho Hwang] Myungmoon Pharmaceutical held a board meeting on the 4th and announced that M2N Co., Ltd. was selected as the preferred negotiation partner regarding the sale of shares by the largest shareholder.
Myungmoon Pharmaceutical stated that it plans to discuss major contract terms with the selected preferred negotiation partner in the future, and if specific details are finalized or important decisions are made during the process, it will disclose them later in accordance with disclosure-related laws and regulations.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
